In the latest legal development in the ongoing 340B contract pharmacy litigation, the United States Court of Appeals for the District of Columbia Circuit ruled earlier this week that the 340B Drug ...
In May 2025, Gov. Jared Polis signed Senate Bill 71 into law, dramatically expanding Colorado’s participation in the 340B ...
The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...
Drugmakers limiting discounted prescription sales to some pharmacies participating in a federal program intended for safety-net providers could pressure profits at the largest pharmacy benefit ...
As the new year begins, gyms are crowded, dietitians’ schedules are packed and dental chairs are filled — signs that Americans are embracing their New Year’s resolutions to focus on health. Alongside ...
Recent polling shows most voters believe lowering out-of-pocket costs is the top health care priority for the country. For low-income and uninsured patients, the impact of rising out-of-pocket costs ...
Hospitals are failing to fulfill the promise of the 340B program, which offers discounted drugs to hospitals that treat a large proportion of underinsured and uninsured patients, The Wall Street ...
The Preserving Rules Ordered for the Entities Covered Through (PROTECT) 340B would block health insurers and pharmacy benefit managers from treating 340B pharmacies differently. The legislation, ...
Leaders say the Medicaid reform would shift millions of dollars away from hospitals and health centers to the state budget, forcing cuts or reduced services for high-need patients. Western New York ...
Founded on pioneering research and industry leadership, ARxIUM® is committed to overcoming the most complex challenges ...
What does it mean to be a patient? For some, it means access to the best doctors and hospitals. For others, it means a courageous battle against a chronic, and perhaps incurable disease. And for many, ...
During a session at AMCP Nexus, panelists provided a historical overview on the 340B drug discount program, highlighting the intentions of the plan and the research gaps leading to misconceptions ...